Innoviva, Inc.
USD23.14
-0.43 (-1.82%)
CEO
Pavel Raifeld
IPO Date
2004-10-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$23.59
Prev. Close
$23.57
Day Low
$23.07
Day High
$23.59
52W Low
$16.52
52W High
$25.15
Market Cap
$1.71B
Volume
0.83M
| 46.5 |
| 31 Dec 2023 | FY | 86.3% | 57.9% | 26.6% | 14.5% | 0.67 | 9.03 | 5.8 |
| 31 Dec 2022 | FY | 95.8% | 64.6% | 37.8% | 17.4% | 0.96 | 3.29 | 4.3 |
| 31 Dec 2021 | FY | 100.0% | 67.8% | 64.1% | 28.7% | 0.95 | 54.02 | 5.3 |
| 31 Dec 2020 | FY | 100.0% | 66.6% | 41.6% | 22.4% | 0.71 | 55.98 | 5.6 |
| 31 Dec 2019 | FY | 100.0% | 60.3% | 50.2% | 21.7% | 1.20 | 80.29 | 9.1 |
| 31 Dec 2018 | FY | 100.0% | 151.4% | 257.2% | 72.1% | 2.49 | 34.92 | 4.5 |
| 31 Dec 2017 | FY | 99.4% | 61.8% | -55.2% | 36.5% | -2.47 | 5.75 | 11.3 |
| 31 Dec 2016 | FY | 99.0% | 44.6% | -16.9% | 15.7% | -2.03 | 9.88 | 19.8 |
| 2.3 |
| 30 Sept 2025 | Q3 | 76.1% | 83.4% | 8.9% | 6.3% | 0.32 | 14.12 | 3.5 |
| 30 Jun 2025 | Q2 | 89.4% | 63.5% | 8.9% | 4.8% | 0.63 | 2.64 | 5.0 |
| 31 Mar 2025 | Q1 | 90.0% | -52.6% | -7.2% | -3.7% | 0.70 | 2.48 | -6.1 |
| 31 Dec 2024 | Q4 | 92.2% | 22.1% | 2.9% | 1.6% | 0.65 | 2.35 | 13.4 |
| 30 Sept 2024 | Q3 | 88.8% | 1.4% | 0.2% | 0.1% | 0.67 | 1.79 | 249.0 |
| 30 Jun 2024 | Q2 | 82.2% | -33.6% | -5.2% | -2.8% | 0.68 | 12.70 | -7.4 |
| 31 Mar 2024 | Q1 | 85.8% | 47.1% | 5.2% | 2.9% | 0.64 | 10.42 | 6.6 |
| 31 Dec 2023 | Q4 | 84.7% | 71.7% | 9.1% | 4.9% | 0.67 | 9.03 | 4.2 |